Intelligence · Clinical Pipeline
Takeda Pipeline
All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.
- Programs
- 393
Quick answer
Takeda has 393 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
placebo
Takeda
Osteoporosis
1 trial -
prucalopride
Takeda
Functional Constipation
1 trial -
rVWF
Takeda
Von Willebrand Disease (VWD)
1 trial -
rozerem
Takeda
Insomnia
1 trial -
teduglutide 0.05 mg/kg/d
Takeda
Short Bowel Syndrome
1 trial -
trifluridine/tipiracil
Takeda
Metastatic Oesogastric Adenocarcinoma
1 trial -
velaglucerase alfa
Takeda
Gaucher Disease, Type 1
1 trial -
vitamin D
Takeda
COVID-19
1 trial -
von Willebrand factor (Recombinant)
Takeda
Von Willebrand Disease
1 trial
Frequently asked questions
How many pipeline programs does Takeda have?
393 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs